col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Elsevier: Joint Bone Spine
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―24 Impact of COVID-19 on initiation of biologic therapy prescriptions for chronic inflammatory diseases Pascal Richette, Matthieu Allez, Vincent Descamps, Lucas Perray, Simon Pilet, Augustin Latourte, Milka Maravic
2 [GO] 2021―Jun―17 Answer to Cabona et al « Isolated musculocutaneous nerve involvement in COVID-19 related Neuralgic amyotrophy» Joint Bone Spine 2021;88:105238 and to Finsterer and Scorza « SARS-CoV-2 or SARS-CoV-2 vaccination associated Parsonage-Turner syndrome». Joint Bone Spine 2021;88:105239 Clemence Coll, Muriel Tessier, Christophe Vandendries, Paul Seror
3 [GO] 2021―Jun―15 SARS-CoV-2 or SARS-CoV-2 vaccination associated Parsonage-Turner syndrome. Comment on : “Neuralgic amyotrophy and Covid 19 infection: 2 cases of spinal accessory nerve palsy” by Coll et al. Joint Bone Spine 2021;88:105196 Josef Finsterer, Fulvio A Scorza
4 [GO] 2021―Jun―12 Isolated musculocutaneous nerve involvement in COVID-19 related Neuralgic amyotrophy. Comment on : “Neuralgic amyotrophy and Covid 19 infection: 2 cases of spinal accessory nerve palsy” by Coll et al. Joint Bone Spine 2021;88:105196 Corrado Cabona, Federico Zaottini, Federico Pistoia, Stefano Grisanti, Cristina Schenone, Flavio Villani, et al. (+4)
5 [GO] 2021―May―26 Phenotypic switch from non-active primary Sjögren's syndrome to severe systemic Lupus erythematosus after COVID-19 infection in an elderly man Guillaume Roger, Arthur Pavot, Isabelle Bonnet, Sophie Ferlicot, Xavier Mariette
6 [GO] 2021―May―13 Physical activity and quality of life of patients with rheumatoid arthritis at the time of COVID-19 lockdown: results from Carenity, an online patient community Florence E Lévy-Weil, Sandrine Jousse-Joulin, Vincent Tiffreau, Raymond Perez, Valentin Morisseau, Alexis Bombezin--Domino, René-Marc Flipo
7 [GO] 2021―Mar―27 Impact of the COVID-19 pandemic on therapeutic management of rheumatoid arthritis in Brittany (France) Baptiste Quere, Alain Saraux, Thierry Marhadour, Sandrine Jousse-Joulin, Divi Cornec, Camille Houssais, et al. (+5)
8 [GO] 2021―Feb―07 May polyenthesitis follow COVID-19? Jacopo Ciaffi, Luana Mancarella, Elena Borlandelli, Giancarlo Facchini, Riccardo Meliconi, Francesco Ursini
9 [GO] 2021―Feb―05 Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica? Ciro Manzo, Alberto Castagna, Giovanni Ruotolo
10 [GO] 2021―Jan―22 COVID-19 epidemiology in rheumatic diseases in Tuscany: a case control study Paolo Francesconi, Fabrizio Cantini, Francesco Profili, Alessandro Mannoni, Benedetta Bellini, Maurizio Benucci
11 [GO] 2020―Nov―02 COVID-19 in French patients with chronic inflammatory rheumatic diseases: clinical features, risk factors and treatment adherence Félicie Costantino, Léa Bahier, Luis Coronel Tarancón, Ariane Leboime, François Vidal, Lamouri Bessalah, et al. (+2)
12 [GO] 2020―Oct―27 Treatment adherence during the COVID-19 pandemic and the impact of confinement on disease activity and emotional status: a survey in 644 rheumatic patients Clementina López-Medina, Lourdes Ladehesa-Pineda, Ignacio Gómez-García, M. Ángeles Puche-Larrubia, J. Miguel Sequí-Sabater, Pedro Armenteros-Ortiz, et al. (+4)
13 [GO] 2020―Oct―27 Can SARS-CoV-2 trigger reactive arthritis? Daniel Wendling, Frank Verhoeven, Mickael Chouk, Clément Prati
14 [GO] 2020―Sep―18 Answer to Vieira et al « Cytokine profile as a prognostic tool in coronavirus disease 2019 ». Joint Bone Spine 2020. Doi:10.1016/j.jbspin.2020.09.006 Luca Quartuccio, Maurizio Benucci, Salvatore De Vita
15 [GO] 2020―Sep―17 Cytokine profile as a prognostic tool in coronavirus disease 2019. Comment on “Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome” by Quartuccio et al. Joint Bone Spine. 2020;87:191-93 Matheus Vieira, Georgina Maalouf, Milena Hasan, Alexandre Le Joncour, Esma Karkeni, Merwan Idir, et al. (+9)
16 [GO] 2020―Jul―01 CoVid-19 related dactyitis Juan Salvatierra, Daniel Martínez-Peñalver, Lucia Salvatierra-Velasco
17 [GO] 2020―Jun―10 Leptomeningeal involvement in a patient with systemic lupus erythematosus infecting by COVID-19 Fadime Guven, Hayri Ogul, Asli Turgut, Alperen Tezcan, Mecit Kantarci
18 [GO] 2020―May―27 Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020 Christophe Richez, René-Marc Flipo, Francis Berenbaum, Alain Cantagrel, Pascal Claudepierre, Françoise Debiais, et al. (+7)
19 [GO] 2020―May―20 Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: a population-based study in the first two months of COVID-19 outbreak in Italy Luca Quartuccio, Francesca Valent, Enrico Pasut, Carlo Tascini, Salvatore De Vita
20 [GO] 2020―Apr―30 How and why rheumatologists are relevant to COVID-19? Renaud Felten, Emmanuel Chatelus, Laurent Arnaud
21 [GO] 2020―Apr―19 Old and new antirheumatic drugs for the treatment of COVID-19 Maurizio Benucci, Arianna Damiani, Maria Infantino, Mariangela Manfredi, Luca Quartuccio
22 [GO] 2020―Apr―19 Implications of COVID-19 for the management of patients with inflammatory rheumatic diseases Christophe Richez, Estibaliz Lazaro, Maël Lemoine, Marie-Elise Truchetet, Thierry Schaeverbeke
23 [GO] 2020―Apr―19 Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome Luca Quartuccio, Luca Semerano, Maurizio Benucci, Marie-Christophe Boissier, Salvatore De Vita


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.010 sec